# Moodys Corp: financial statements, quarterly

MCO · NYSE · CIK 1059556 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mco.md) · [Financials](/companies/mco/financials.md) · [Filings](/companies/mco/filings.md) · [Insiders](/companies/mco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,480 d](/filings/0001628280-26-009136.md) | [1,786](/filings/0001059556-25-000121.md) | [1,817](/filings/0001059556-25-000169.md) | [1,813](/filings/0001628280-25-046118.md) | [1,672 d](/filings/0001628280-26-009136.md) | [1,924](/filings/0001628280-26-026848.md) | [1,898](/filings/0001628280-26-049398.md) | [2,007](/filings/0001628280-26-066731.md) | [1,889 d](/filings/0001628280-26-009136.md) | [2,079](/filings/0001628280-26-026848.md) | [2,185](/filings/0001628280-26-049398.md) | [2,023](/filings/0001628280-26-066731.md) |
| Cost of revenue | $m | [421 d](/filings/0001628280-26-009136.md) | [467](/filings/0001059556-25-000121.md) | [469](/filings/0001059556-25-000169.md) | [512](/filings/0001628280-25-046118.md) | [497 d](/filings/0001628280-26-009136.md) | [491](/filings/0001628280-26-026848.md) | [489](/filings/0001628280-26-049398.md) | [492](/filings/0001628280-26-066731.md) | [501 d](/filings/0001628280-26-009136.md) | [531](/filings/0001628280-26-026848.md) | [518](/filings/0001628280-26-049398.md) | [524](/filings/0001628280-26-066731.md) |
| Selling, general and administrative | $m | [428 d](/filings/0001628280-26-009136.md) | [413](/filings/0001059556-25-000121.md) | [446](/filings/0001059556-25-000169.md) | [434](/filings/0001628280-25-046118.md) | [442 d](/filings/0001628280-26-009136.md) | [439](/filings/0001628280-26-026848.md) | [443](/filings/0001628280-26-049398.md) | [453](/filings/0001628280-26-066731.md) | [468 d](/filings/0001628280-26-009136.md) | [477](/filings/0001628280-26-026848.md) | [463](/filings/0001628280-26-049398.md) | [442](/filings/0001628280-26-066731.md) |
| Operating income | $m | [498 d](/filings/0001628280-26-009136.md) | [801](/filings/0001059556-25-000121.md) | [775](/filings/0001059556-25-000169.md) | [738](/filings/0001628280-25-046118.md) | [561 d](/filings/0001628280-26-009136.md) | [846](/filings/0001628280-26-026848.md) | [818](/filings/0001628280-26-049398.md) | [917](/filings/0001628280-26-066731.md) | [770 d](/filings/0001628280-26-009136.md) | [922](/filings/0001628280-26-026848.md) | [1,046](/filings/0001628280-26-049398.md) | [906](/filings/0001628280-26-066731.md) |
| Income tax | $m | [110 d](/filings/0001628280-26-009136.md) | [175](/filings/0001059556-25-000121.md) | [166](/filings/0001059556-25-000169.md) | [169](/filings/0001628280-25-046118.md) | [130 d](/filings/0001628280-26-009136.md) | [179](/filings/0001628280-26-026848.md) | [193](/filings/0001628280-26-049398.md) | [220](/filings/0001628280-26-066731.md) | [76.0 d](/filings/0001628280-26-009136.md) | [209](/filings/0001628280-26-026848.md) | [292](/filings/0001628280-26-049398.md) | [232](/filings/0001628280-26-066731.md) |
| Net income | $m | [340 d](/filings/0001628280-26-009136.md) | [577](/filings/0001059556-25-000121.md) | [552](/filings/0001059556-25-000169.md) | [534](/filings/0001628280-25-046118.md) | [395 d](/filings/0001628280-26-009136.md) | [625](/filings/0001628280-26-026848.md) | [578](/filings/0001628280-26-049398.md) | [646](/filings/0001628280-26-066731.md) | [610 d](/filings/0001628280-26-009136.md) | [661](/filings/0001628280-26-026848.md) | [878](/filings/0001628280-26-049398.md) | [734](/filings/0001628280-26-066731.md) |
| Diluted EPS | $ per share | not reported | [3.15](/filings/0001059556-25-000121.md) | [3.02](/filings/0001059556-25-000169.md) | [2.93](/filings/0001628280-25-046118.md) | not reported | [3.46](/filings/0001628280-26-026848.md) | [3.21](/filings/0001628280-26-049398.md) | [3.60](/filings/0001628280-26-066731.md) | not reported | [3.73](/filings/0001628280-26-026848.md) | [5.03](/filings/0001628280-26-049398.md) | [4.24](/filings/0001628280-26-066731.md) |
| Basic EPS | $ per share | not reported | [3.16](/filings/0001059556-25-000121.md) | [3.03](/filings/0001059556-25-000169.md) | [2.94](/filings/0001628280-25-046118.md) | not reported | [3.47](/filings/0001628280-26-026848.md) | [3.22](/filings/0001628280-26-049398.md) | [3.61](/filings/0001628280-26-066731.md) | not reported | [3.74](/filings/0001628280-26-026848.md) | [5.04](/filings/0001628280-26-049398.md) | [4.25](/filings/0001628280-26-066731.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.1](/filings/0001059556-25-000025.md) | [2.5](/filings/0001059556-24-000090.md) | [2.6](/filings/0001059556-24-000128.md) | [2.6](/filings/0001059556-24-000184.md) | [2.4](/filings/0001628280-26-009136.md) | [2.1](/filings/0001059556-25-000121.md) | [2.2](/filings/0001059556-25-000169.md) | [2.2](/filings/0001628280-25-046118.md) | [2.4](/filings/0001628280-26-066731.md) | [1.5](/filings/0001628280-26-026848.md) | [1.5](/filings/0001628280-26-049398.md) | [1.5](/filings/0001628280-26-066731.md) |
| Current assets | $bn | [4.3](/filings/0001059556-25-000025.md) | [4.8](/filings/0001059556-24-000090.md) | [4.9](/filings/0001059556-24-000128.md) | [5.4](/filings/0001059556-24-000184.md) | [5.3](/filings/0001628280-26-009136.md) | [4.6](/filings/0001059556-25-000121.md) | [4.6](/filings/0001059556-25-000169.md) | [4.6](/filings/0001628280-25-046118.md) | [5.2](/filings/0001628280-26-066731.md) | [4.2](/filings/0001628280-26-026848.md) | [4.0](/filings/0001628280-26-049398.md) | [4.2](/filings/0001628280-26-066731.md) |
| Total assets | $bn | [14.6](/filings/0001059556-25-000025.md) | [15.0](/filings/0001059556-24-000090.md) | [15.0](/filings/0001059556-24-000128.md) | [15.8](/filings/0001059556-24-000184.md) | [15.5](/filings/0001628280-26-009136.md) | [15.1](/filings/0001059556-25-000121.md) | [15.5](/filings/0001059556-25-000169.md) | [15.4](/filings/0001628280-25-046118.md) | [15.8](/filings/0001628280-26-066731.md) | [14.7](/filings/0001628280-26-026848.md) | [14.7](/filings/0001628280-26-049398.md) | [14.8](/filings/0001628280-26-066731.md) |
| Current liabilities | $bn | [2.5](/filings/0001059556-25-000025.md) | [3.4](/filings/0001059556-24-000090.md) | [3.2](/filings/0001059556-24-000128.md) | [3.2](/filings/0001059556-24-000184.md) | [3.6](/filings/0001628280-26-009136.md) | [2.9](/filings/0001059556-25-000121.md) | [2.6](/filings/0001059556-25-000169.md) | [2.5](/filings/0001628280-25-046118.md) | [3.0](/filings/0001628280-26-066731.md) | [3.6](/filings/0001628280-26-026848.md) | [3.3](/filings/0001628280-26-049398.md) | [3.3](/filings/0001628280-26-066731.md) |
| Total liabilities | $bn | [11.1](/filings/0001059556-25-000025.md) | [11.3](/filings/0001059556-24-000090.md) | [11.1](/filings/0001059556-24-000128.md) | [11.7](/filings/0001059556-24-000184.md) | [11.8](/filings/0001628280-26-009136.md) | [11.2](/filings/0001059556-25-000121.md) | [11.4](/filings/0001059556-25-000169.md) | [11.3](/filings/0001628280-25-046118.md) | [11.6](/filings/0001628280-26-066731.md) | [11.6](/filings/0001628280-26-026848.md) | [11.5](/filings/0001628280-26-049398.md) | [11.4](/filings/0001628280-26-066731.md) |
| Long-term debt | $bn | [7.0](/filings/0001059556-25-000025.md) | [6.3](/filings/0001059556-24-000090.md) | [6.3](/filings/0001059556-24-000128.md) | [6.9](/filings/0001059556-24-000184.md) | [6.7](/filings/0001628280-26-009136.md) | [6.8](/filings/0001059556-25-000121.md) | [7.0](/filings/0001059556-25-000169.md) | [7.0](/filings/0001628280-25-046118.md) | [7.0](/filings/0001628280-26-066731.md) | [6.4](/filings/0001628280-26-026848.md) | [6.4](/filings/0001628280-26-049398.md) | [6.3](/filings/0001628280-26-066731.md) |
| Current portion of debt | $bn | [0.0](/filings/0001059556-25-000025.md) | [0.7](/filings/0001059556-24-000090.md) | [0.7](/filings/0001059556-24-000128.md) | [0.7](/filings/0001059556-24-000184.md) | [0.7](/filings/0001628280-26-009136.md) | [0.0](/filings/0001059556-25-000121.md) | [0.0](/filings/0001059556-25-000169.md) | [0.0](/filings/0001628280-25-046118.md) | [0.0](/filings/0001628280-26-066731.md) | [0.6](/filings/0001628280-26-026848.md) | [0.6](/filings/0001628280-26-049398.md) | [0.6](/filings/0001628280-26-066731.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [3.3](/filings/0001059556-25-000025.md) | [3.6](/filings/0001059556-24-000090.md) | [3.8](/filings/0001059556-24-000128.md) | [3.9](/filings/0001059556-24-000184.md) | [3.6](/filings/0001628280-26-009136.md) | [3.7](/filings/0001059556-25-000121.md) | [3.9](/filings/0001059556-25-000169.md) | [4.0](/filings/0001628280-25-046118.md) | [4.1](/filings/0001628280-26-066731.md) | [3.0](/filings/0001628280-26-026848.md) | [3.0](/filings/0001628280-26-049398.md) | [3.3](/filings/0001628280-26-066731.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [477 d](/filings/0001628280-26-009136.md) | [775](/filings/0001059556-25-000121.md) | [686 d](/filings/0001059556-25-000169.md) | [703 d](/filings/0001628280-25-046118.md) | [674 d](/filings/0001628280-26-009136.md) | [757](/filings/0001628280-26-026848.md) | [543 d](/filings/0001628280-26-049398.md) | [743 d](/filings/0001628280-26-066731.md) | [858 d](/filings/0001628280-26-009136.md) | [939](/filings/0001628280-26-026848.md) | [779 d](/filings/0001628280-26-049398.md) | [753 d](/filings/0001628280-26-066731.md) |
| Capital expenditure | $m | [73.0 d](/filings/0001628280-26-009136.md) | [78.0](/filings/0001059556-25-000121.md) | [93.0 d](/filings/0001059556-25-000169.md) | [72.0 d](/filings/0001628280-25-046118.md) | [74.0 d](/filings/0001628280-26-009136.md) | [85.0](/filings/0001628280-26-026848.md) | [75.0 d](/filings/0001628280-26-049398.md) | [85.0 d](/filings/0001628280-26-066731.md) | [81.0 d](/filings/0001628280-26-009136.md) | [95.0](/filings/0001628280-26-026848.md) | [91.0 d](/filings/0001628280-26-049398.md) | [85.0 d](/filings/0001628280-26-066731.md) |
| Dividends paid | $m | [140 d](/filings/0001628280-26-009136.md) | [155](/filings/0001059556-25-000121.md) | [154 d](/filings/0001059556-25-000169.md) | [156 d](/filings/0001628280-25-046118.md) | [155 d](/filings/0001628280-26-009136.md) | [195](/filings/0001628280-26-026848.md) | [171 d](/filings/0001628280-26-049398.md) | [168 d](/filings/0001628280-26-066731.md) | [167 d](/filings/0001628280-26-009136.md) | [185](/filings/0001628280-26-026848.md) | [180 d](/filings/0001628280-26-049398.md) | [178 d](/filings/0001628280-26-066731.md) |
| Share repurchases | $m | [212 d](/filings/0001628280-26-009136.md) | [120](/filings/0001059556-25-000121.md) | [264 d](/filings/0001059556-25-000169.md) | [428 d](/filings/0001628280-25-046118.md) | [480 d](/filings/0001628280-26-009136.md) | [373](/filings/0001628280-26-026848.md) | [284 d](/filings/0001628280-26-049398.md) | [513 d](/filings/0001628280-26-066731.md) | [437 d](/filings/0001628280-26-009136.md) | [1,471](/filings/0001628280-26-026848.md) | [694 d](/filings/0001628280-26-049398.md) | [388 d](/filings/0001628280-26-066731.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [184](/filings/0001059556-24-000090.md) | [184](/filings/0001059556-24-000128.md) | [184](/filings/0001059556-24-000184.md) | [183](/filings/0001059556-25-000121.md) | [183](/filings/0001059556-25-000169.md) | [183](/filings/0001628280-25-046118.md) | [181](/filings/0001628280-26-026848.md) | [180](/filings/0001628280-26-049398.md) | [180](/filings/0001628280-26-066731.md) | [177](/filings/0001628280-26-026848.md) | [175](/filings/0001628280-26-049398.md) | [173](/filings/0001628280-26-066731.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 172,400,000 at 2026-09-30, from the cover of the [10-Q filed 2026-10-21](/filings/0001628280-26-066731.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 17:50 ET. No prices; not investment advice.